Australia markets closed

Clover Health Investments, Corp. (CLOV)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.8200-0.0433 (-5.02%)
At close: 04:00PM EDT
0.8201 +0.00 (+0.01%)
After hours: 07:23PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 407.08M
Enterprise value 68.32M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.19
Price/book (mrq)1.39
Enterprise value/revenue N/A
Enterprise value/EBITDA -435.39

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-15.64%
S&P500 52-week change 326.27%
52-week high 31.6300
52-week low 30.6060
50-day moving average 30.7434
200-day moving average 30.9818

Share statistics

Avg vol (3-month) 39.45M
Avg vol (10-day) 36.58M
Shares outstanding 5406.79M
Implied shares outstanding 6496.44M
Float 8376.06M
% held by insiders 17.64%
% held by institutions 123.70%
Shares short (30 Apr 2024) 447.81M
Short ratio (30 Apr 2024) 47.75
Short % of float (30 Apr 2024) 411.93%
Short % of shares outstanding (30 Apr 2024) 49.63%
Shares short (prior month 28 Mar 2024) 443.98M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -7.77%
Operating margin (ttm)-6.44%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)2.06B
Revenue per share (ttm)4.21
Quarterly revenue growth (yoy)-34.50%
Gross profit (ttm)N/A
EBITDA -130.49M
Net income avi to common (ttm)-156.83M
Diluted EPS (ttm)-0.3200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)N/A
Total cash per share (mrq)N/A
Total debt (mrq)N/A
Total debt/equity (mrq)1.63%
Current ratio (mrq)N/A
Book value per share (mrq)0.59

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A